Aldo-Union will be at Pharma Partnering with quality respiratory drugs. It is a privately-owned pharmaceutical group headquartered in Barcelona, Spain, with a global presence as a major player in the generic respiratory drugs industry. With over 60 years of experience, Aldo-Union has built a reputation for producing high-quality and affordable generic respiratory drugs, including asthma inhalers and nasal sprays. Aldo-Union has a highly qualified and motivated international team of aprox 300 employees and a turnover of around 100€ Million, making it one of the leading specialized manufacturers in the industry.
Aldo-Union has a strong focus on research and development, which has led to the creation of innovative products and technologies. Its state-of-the-art production facilities and integrated regulatory support ensure the quality and safety of its products, making Aldo-Union a trusted supplier to its global customers.
Aldo-Union is participating in PharmaVenue Madrid, one of the most important events in the pharmaceutical industry, which will take place on May 2023. This event brings together pharmaceutical companies, distributors, and other industry professionals from around the world to network, exchange knowledge, discuss the latest trends in the industry and sign new collaboration agreements.
How can you benefit from meeting with Aldo-Union?
Participating in PharmaVenue Madrid will provide Aldo-Union with several benefits. Firstly, it will allow Aldo-Union to showcase its range of respiratory products, including its asthma inhalers, nasal sprays, and nebulization ampules. These products have perfect dossiers and are highly sought-after by customers worldwide, thanks to their quality and affordability.
Secondly, Aldo-Union will be able to meet with potential new distributors and expand its international partnership network, which already spans more than 85 countries. By out-licensing its products and dossiers, Aldo-Union can reach new markets and increase its revenue, while also providing patients with access to high-quality respiratory drugs.
Finally, Aldo-Union will be able to explore opportunities to acquire new respiratory products, particularly those under patent or high-technology generic respiratory products for the Spanish market. With a strong sales force focused on promoting respiratory products in Spain, Aldo-Union is well-positioned to introduce new products and technologies to the market and grow its business.
At PharmaVenue Madrid, Aldo-Union will have the opportunity to connect with other industry professionals and learn about the latest advancements in the pharmaceutical industry. By participating in this event, Aldo-Union will be able to showcase its strengths and explore new opportunities for growth, both in Spain and globally.
Aldo-Union With Quality Respiratory Drugs at Pharma Partnering
In conclusion, Aldo-Union is a leading player in the generic respiratory drugs industry, with a strong focus on research and development, quality, and affordability. Participating in PharmaVenue Madrid will allow Aldo-Union to showcase its products, expand its international partnership network, and explore new opportunities for growth. As a result, patients around the world will have access to high-quality respiratory drugs, while Aldo-Union will continue to grow as a trusted supplier in the pharmaceutical industry.